PL366005A1 - Nowe geny proteaz serynowych pokrewnych do DPPIV - Google Patents

Nowe geny proteaz serynowych pokrewnych do DPPIV

Info

Publication number: PL366005A1
Authority: PL; Poland
Prior art keywords: dppiv; serine protease; genes related; protease genes; novel serine
Prior art date: 2000-10-12

Application number

PL01366005A

Other languages

English (en)

Inventor

Steve Qi

Karen O. Akinsanya

Pierre J-M Riviere

Jean-Louis Junien

Original Assignee

Ferring Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-12

Filing date

2001-10-12

Publication date

2005-01-24

2001-10-12 Application filed by Ferring Bv filed Critical Ferring Bv

2005-01-24 Publication of PL366005A1 publication Critical patent/PL366005A1/pl

Links

101000964562 Homo sapiens Zinc finger FYVE domain-containing protein 9 Proteins 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Neurology (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Diabetes (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Oncology (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Physics & Mathematics (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Plant Pathology (AREA)
Obesity (AREA)
Virology (AREA)

PL01366005A 2000-10-12 2001-10-12 Nowe geny proteaz serynowych pokrewnych do DPPIV PL366005A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US24011700P	2000-10-12	2000-10-12

Publications (1)

Publication Number	Publication Date
PL366005A1 true PL366005A1 (pl)	2005-01-24

Family

ID=22905181

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL01366005A PL366005A1 (pl)	2000-10-12	2001-10-12	Nowe geny proteaz serynowych pokrewnych do DPPIV

Country Status (17)

Country	Link
US (2)	US6844180B2 (pl)
EP (1)	EP1346033A2 (pl)
JP (1)	JP2004528812A (pl)
KR (1)	KR100875221B1 (pl)
CN (2)	CN100354417C (pl)
AU (2)	AU2002213138B2 (pl)
CA (1)	CA2425001A1 (pl)
CZ (1)	CZ20031301A3 (pl)
HU (1)	HUP0301356A3 (pl)
IL (2)	IL155245A0 (pl)
MX (1)	MXPA03003191A (pl)
NO (1)	NO329842B1 (pl)
NZ (1)	NZ525443A (pl)
PL (1)	PL366005A1 (pl)
RU (1)	RU2305133C2 (pl)
WO (1)	WO2002031134A2 (pl)
ZA (1)	ZA200303306B (pl)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6979697B1 (en) *	1998-08-21	2005-12-27	Point Therapeutics, Inc.	Regulation of substrate activity
WO2001019866A1 (en) *	1999-09-10	2001-03-22	The University Of Sydney	Dipeptidyl peptidases
US20040047853A1 (en) *	2000-06-09	2004-03-11	Dahl Soren W	Purified proenzyme of dipeptidyl peptidase i (pro-dppi)
AUPR107800A0 (en) *	2000-10-27	2000-11-23	University Of Sydney, The	Peptide and nucleic acid molecule ii
GB0101760D0 (en) *	2001-01-23	2001-03-07	Glaxo Group Ltd	Novel protein
CA2483507A1 (en) *	2001-04-24	2002-10-31	Isis Innovation Limited	Enzyme and snp marker for disease
JP2004533449A (ja)	2001-05-11	2004-11-04	ボード　オブ　リージェンツ，　ザ　ユニバーシティ　オブ　テキサス　システム	Ｃｄ２６を発現している細胞に関連する疾患の治療としての抗ｃｄ２６モノクローナル抗体
DE10150203A1 (de)	2001-10-12	2003-04-17	Probiodrug Ag	Peptidylketone als Inhibitoren der DPIV
US6709651B2 (en) *	2001-07-03	2004-03-23	B.M.R.A. Corporation B.V.	Treatment of substance P-related disorders
WO2003057916A2 (en) *	2002-01-09	2003-07-17	Riken	Cancer profiles
ES2306781T3 (es)	2002-08-09	2008-11-16	Prosidion Ltd.	Inhibidores de la dipeptidil-peptidasa iv para disminucion de la tasa de aumento cronico de peso.
US20040242568A1 (en)	2003-03-25	2004-12-02	Syrrx, Inc.	Dipeptidyl peptidase inhibitors
WO2004103993A1 (en)	2003-05-14	2004-12-02	Syrrx, Inc.	Dipeptidyl peptidase inhibitors
EP1506967B1 (en)	2003-08-13	2007-11-21	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
US7678909B1 (en)	2003-08-13	2010-03-16	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
US7169926B1 (en)	2003-08-13	2007-01-30	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
EP1699777B1 (en)	2003-09-08	2012-12-12	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
US7732446B1 (en)	2004-03-11	2010-06-08	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
MXPA06010571A (es)	2004-03-15	2007-02-16	Takeda Pharmaceutical	Inhibidores de dipeptidil peptidasa.
WO2005106021A1 (en) *	2004-04-28	2005-11-10	Bayer Healthcare Ag	Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 8 (dpp8)
EP1745293A1 (en) *	2004-04-28	2007-01-24	Bayer HealthCare AG	Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 9 (dpp9)
US7687638B2 (en) *	2004-06-04	2010-03-30	Takeda San Diego, Inc.	Dipeptidyl peptidase inhibitors
WO2006019965A2 (en)	2004-07-16	2006-02-23	Takeda San Diego, Inc.	Dipeptidyl peptidase inhibitors
US20060063719A1 (en) *	2004-09-21	2006-03-23	Point Therapeutics, Inc.	Methods for treating diabetes
EP1828192B1 (en) *	2004-12-21	2014-12-03	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
ME02005B (me)	2005-09-14	2012-08-31	Takeda Pharmaceuticals Co	Inhibitori dipeptidil peptidaze za lečenje dijabetesa
WO2007033265A1 (en) *	2005-09-14	2007-03-22	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors for treating diabetis
CN101360723A (zh)	2005-09-16	2009-02-04	武田药品工业株式会社	制备嘧啶二酮衍生物的方法
WO2007047205A2 (en) *	2005-10-11	2007-04-26	Amano Enzyme Usa Co., Ltd.	Enzyme inhibitors of pai-1
WO2007054577A1 (en)	2005-11-14	2007-05-18	Probiodrug Ag	Cyclopropyl-fused pyrrolidine derivatives as dipeptidyl peptidase iv inhibitors
WO2007112347A1 (en)	2006-03-28	2007-10-04	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
MX2008013130A (es)	2006-04-12	2008-11-19	Probiodrug Ag	Inhibidores de enzima.
US8324383B2 (en)	2006-09-13	2012-12-04	Takeda Pharmaceutical Company Limited	Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en)	2006-11-29	2008-10-01	Takeda Pharmaceutical	Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
CN101259119B (zh) *	2007-03-08	2010-05-19	上海市计划生育科学研究所	一种丝氨酸蛋白酶抑制剂及其衍生物在生育调节中的应用
US8093236B2 (en)	2007-03-13	2012-01-10	Takeda Pharmaceuticals Company Limited	Weekly administration of dipeptidyl peptidase inhibitors
US9593148B2 (en) *	2012-11-02	2017-03-14	Georg-August-Universitat Gottingen Stiftung Offentlichen Rechts	DPP8 and DPP9 peptide inhibitors
MX2021011726A (es) *	2019-03-26	2021-10-22	Encodia Inc	Escindasas modificadas, usos de las mismas y kits relacionados.
US11427814B2 (en)	2019-03-26	2022-08-30	Encodia, Inc.	Modified cleavases, uses thereof and related kits

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6291662B1 (en)	1984-12-05	2001-09-18	Amgen Inc.	Recombinant methods for production of serine protease inhibitors and DNA sequences
IL111785A0 (en)	1993-12-03	1995-01-24	Ferring Bv	Dp-iv inhibitors and pharmaceutical compositions containing them
AU2501200A (en) *	1999-01-11	2000-08-01	Incyte Pharmaceuticals, Inc.	Human peptidases
EP1165784A2 (en)	1999-03-31	2002-01-02	Curagen Corporation	Nucleic acids including open reading frames encoding polypeptides; "orfx"
WO2001019866A1 (en)	1999-09-10	2001-03-22	The University Of Sydney	Dipeptidyl peptidases
CN1307128A (zh) *	2000-01-26	2001-08-08	上海博道基因技术有限公司	一种新的多肽——人二肽氨肽酶28和编码这种多肽的多核苷酸
AU2001269836A1 (en) *	2000-06-16	2002-01-02	Incyte Genomics, Inc.	Proteases

2001
- 2001-10-12 CZ CZ20031301A patent/CZ20031301A3/cs unknown
- 2001-10-12 JP JP2002534503A patent/JP2004528812A/ja active Pending
- 2001-10-12 AU AU2002213138A patent/AU2002213138B2/en not_active Ceased
- 2001-10-12 CA CA002425001A patent/CA2425001A1/en not_active Abandoned
- 2001-10-12 PL PL01366005A patent/PL366005A1/pl unknown
- 2001-10-12 EP EP01981501A patent/EP1346033A2/en not_active Ceased
- 2001-10-12 KR KR1020037005169A patent/KR100875221B1/ko not_active Expired - Fee Related
- 2001-10-12 AU AU1313802A patent/AU1313802A/xx active Pending
- 2001-10-12 CN CNB018173128A patent/CN100354417C/zh not_active Expired - Fee Related
- 2001-10-12 NZ NZ525443A patent/NZ525443A/en unknown
- 2001-10-12 WO PCT/US2001/031874 patent/WO2002031134A2/en not_active Ceased
- 2001-10-12 US US09/976,674 patent/US6844180B2/en not_active Expired - Fee Related
- 2001-10-12 MX MXPA03003191A patent/MXPA03003191A/es active IP Right Grant
- 2001-10-12 RU RU2003112700/13A patent/RU2305133C2/ru not_active IP Right Cessation
- 2001-10-12 IL IL15524501A patent/IL155245A0/xx unknown
- 2001-10-12 HU HU0301356A patent/HUP0301356A3/hu unknown
- 2001-10-12 CN CNA2007101850111A patent/CN101270362A/zh active Pending
2003
- 2003-04-03 IL IL155245A patent/IL155245A/en not_active IP Right Cessation
- 2003-04-11 NO NO20031702A patent/NO329842B1/no not_active IP Right Cessation
- 2003-04-29 ZA ZA200303306A patent/ZA200303306B/en unknown
2004
- 2004-11-05 US US10/982,512 patent/US7157241B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO2002031134A2 (en)	2002-04-18
CN100354417C (zh)	2007-12-12
ZA200303306B (en)	2004-08-12
IL155245A (en)	2010-04-15
US7157241B2 (en)	2007-01-02
US20050059081A1 (en)	2005-03-17
AU2002213138B2 (en)	2006-07-20
AU1313802A (en)	2002-04-22
NO20031702L (no)	2003-05-15
CN1636061A (zh)	2005-07-06
US6844180B2 (en)	2005-01-18
RU2305133C2 (ru)	2007-08-27
NO329842B1 (no)	2011-01-10
HUP0301356A3 (en)	2010-03-29
EP1346033A2 (en)	2003-09-24
JP2004528812A (ja)	2004-09-24
WO2002031134A3 (en)	2003-07-17
MXPA03003191A (es)	2004-12-03
KR100875221B1 (ko)	2008-12-19
NZ525443A (en)	2006-04-28
HUP0301356A2 (hu)	2003-10-28
HK1078104A1 (zh)	2006-03-03
IL155245A0 (en)	2003-11-23
KR20030038815A (ko)	2003-05-16
NO20031702D0 (no)	2003-04-11
CZ20031301A3 (cs)	2003-10-15
US20020115843A1 (en)	2002-08-22
CA2425001A1 (en)	2002-04-18
CN101270362A (zh)	2008-09-24

Legal Events

Date	Code	Title	Description
2012-10-31	DISC	Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
AU1313802A (en)	2002-04-22	Novel serine protease genes related to dppiv
AU7961401A (en)	2002-03-04	Subtilase enzymes
AU1339302A (en)	2002-05-06	Biaryl compounds as serine protease inhibitors
AU2001271427A1 (en)	2002-01-08	Novel proteases
GB0017387D0 (en)	2000-08-30	Novel enzyme
ZA992447B (en)	2000-10-10	Quinoxalinones as serine protease inhibitors.
AU2108601A (en)	2001-06-25	Salicylamides as serine protease inhibitors
HUP0301795A3 (en)	2006-11-28	Dna encoding human serine protease d-g
EP1179052A4 (en)	2004-12-15	SERINE PROTEASES
GB0015490D0 (en)	2000-08-16	Novel formulations
AU2002210379A1 (en)	2002-04-22	Subtilase variants
GB2364338B (en)	2004-01-28	Improvements relating to construction
GB0028814D0 (en)	2001-01-10	Improvements relating to biosorbtion
EP1206233A4 (en)	2004-04-14	Serine proteases
EP1382395A4 (en)	2007-01-17	CRUSHING DEVICE
IL146157A0 (en)	2002-07-25	Improvements to el type pulverizers
GB2359653B (en)	2004-05-26	Improvements relating to entertainment machines
GB2367065A8 (en)	2002-03-27	Enzyme-containing laundry booster compositions
GB2386010B (en)	2004-11-24	Improvements relating to signal mixers
AU2001278787A1 (en)	2002-03-04	Novel protease gene
GB2385476B (en)	2004-11-24	Improvements relating to signal mixers
AU2002219516A1 (en)	2002-07-08	Novel protease
GB0000427D0 (en)	2000-03-01	Improvements relating to games
GB0025715D0 (en)	2000-12-06	Improvements relating to haribrushes
HK1056894A (en)	2004-03-05	Novel proteases